Assay News and Research

RSS
New assay uses a drop of blood to detect patients' resistance to antimalarial drugs

New assay uses a drop of blood to detect patients' resistance to antimalarial drugs

Rapid rise in Big Data facilitates digital transformation of healthcare

Rapid rise in Big Data facilitates digital transformation of healthcare

Identifying colorectal cancer subtypes in patients could help provide better care

Identifying colorectal cancer subtypes in patients could help provide better care

Identifying subtype of colorectal cancer may help oncologists determine most effective treatment

Identifying subtype of colorectal cancer may help oncologists determine most effective treatment

Smart phone plus nanoscale porous silicon equals simple home medical tests

Smart phone plus nanoscale porous silicon equals simple home medical tests

Roche Diagnostics launches first in vitro diagnostic ROS1 immunohistochemistry assay

Roche Diagnostics launches first in vitro diagnostic ROS1 immunohistochemistry assay

Bruker launches timsTOF fleX with ESI/MALDI capability for SpatialOMx at ASMS 2019

Bruker launches timsTOF fleX with ESI/MALDI capability for SpatialOMx at ASMS 2019

Scientists 'on the right track' toward universal flu vaccine

Scientists 'on the right track' toward universal flu vaccine

Quanterix raises $49.7 million and announces introduction of latest model Simoa HD-X Analyzer at Bio 2019 International Convention

Quanterix raises $49.7 million and announces introduction of latest model Simoa HD-X Analyzer at Bio 2019 International Convention

Study reveals novel indicator of protection against influenza virus infection

Study reveals novel indicator of protection against influenza virus infection

New diagnostic tool helps develop improved RDTs and support public health surveillance

New diagnostic tool helps develop improved RDTs and support public health surveillance

Quanterix expands headquarters to new, state-of-the-art facility in Billerica, Mass. as demand continues to grow for its disruptive Simoa platforms

Quanterix expands headquarters to new, state-of-the-art facility in Billerica, Mass. as demand continues to grow for its disruptive Simoa platforms

Expedeon announces addition of CaptSure DIY ELISA to immunoassay product portfolio

Expedeon announces addition of CaptSure DIY ELISA to immunoassay product portfolio

New laboratory test has potential to accurately predict spread of breast cancer

New laboratory test has potential to accurately predict spread of breast cancer

New technology helps reduce cost and time needed to do common laboratory tests

New technology helps reduce cost and time needed to do common laboratory tests

Marine natural compounds could be potential treatments for triple negative breast cancer

Marine natural compounds could be potential treatments for triple negative breast cancer

Quanterix announces $50,000 in grants to support promising oncology research

Quanterix announces $50,000 in grants to support promising oncology research

LC-MS/MS test for progesterone outperforms traditional immunoassays

LC-MS/MS test for progesterone outperforms traditional immunoassays

Novel device could enable early diagnosis and treatment development for Parkinson's disease

Novel device could enable early diagnosis and treatment development for Parkinson's disease

RIT faculty-researcher develops microfluidic device for early detection of Ebola virus

RIT faculty-researcher develops microfluidic device for early detection of Ebola virus

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.